Oklahoma State Medical Association
Proper Prescribing (Online Course)
About this Course
The post-test and evaluation must be completed if the activity is to be used for CME credit. The score required for passing 80%.
OSMA Members: FREE
OSMA Non-Members: $75
Read the following information before beginning the educational activity
Check the box next to the certification statement
Click the Continue to Course link at the bottom of the page
Complete pre-test (if applicable)
Study the educational activity including viewing video materials if applicable
Complete the CME post-test and evaluation
After successful completion of the CME post-test and evaluation, you will receive credit and have the opportunity to download and print a participation certificate
The educational design addresses the needs and issues of healthcare providers including physicians, MDs and DOs.
The urgency of patients’ needs, the demonstrated effectiveness of opioid analgesics for the management of acute pain, and the limited therapeutic alternatives for chronic pain have combined to produce an overreliance on opioid medications in the United States, with associated alarming increases in diversion, overdose, and addiction. Given the prevalence of chronic pain and its often disabling effects, it is not surprising that opioid analgesics are now the most commonly prescribed class of medications in the United State. In 2015, Oklahoma providers wrote 101.7 opioid prescriptions per 100 persons (3.97 million prescriptions). In the same year, the average U.S. rate was 70 opioid prescriptions per 100 persons. In response to this disturbing trend, the Oklahoma legislature first passed Senate Bill 1446 in 2018 followed by Senate Bill 848 in 2019 both of which place limits on opioid prescribing. Additionally, the laws place greater responsibility on physicians by requiring one hour of continuing education in pain management or in opioid abuse and addiction each year before the physician renews his or her license to practice and by providing for disciplinary action if a practitioner fails to check the Oklahoma Prescription Monitoring Program database. The law also aims to generally increase communication between prescribers and patients by requiring documented discussions on the risks associated with opioids. Implementation of this law created a number of unintended consequences for both physicians and patients. This session will create an opportunity for physicians to be familiar with the latest requirements for prescribing under Oklahoma law.
After attending the activity, the physician should be able to:
1. Discuss and comprehend new Oklahoma laws related to medical marijuana, e-prescribing and opioid prescribing; and
2. Discuss and understand the significance of increased enforcement activity by regulatory bodies; and
3. Understand the significance of a recent Supreme Court Case impacting anti-referral provisions in managed care contracts; and
4. Understand changes in OCR’s interpretation of “individual access” requirements under HIPAA and how to implement them.
Accreditation and Disclosure Statement
The Oklahoma State Medical Association (OSMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The OSMA designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The Faculty/Reviewer and OSMA CME Planning Committee have no relevant financial relationships to disclose.
“The Oklahoma State Medical Association has been surveyed by the Accreditation Council for Continuing Medical Education (ACCME) and awarded Accreditation with Commendation for six years as a provider of continuing medical education for physicians.
The ACCME accreditation seeks to assure the medical community and the public that the Oklahoma State Medical Association provides physicians with relevant, effective, practice-based continuing medical education that supports US health care quality improvements.
The ACCME employs a rigorous, multilevel process for evaluating institutions’ continuing medical education programs according to the high accreditation standards adopted by all seven ACCME member organizations. These organizations of medicine in the US are the American Board of Medical Specialties, the American Hospital Association, the American Medical Association, the Association for Hospital Medical Education, the Association of American Medical Colleges, the Council of Medical Specialty Societies, and the Federation of State Medical Boards of the US, Inc.”
Cori H. Loomis, JD, Christensen Law Group, P.L.L.C.
Cori H. Loomis’ primary focus is on the representation of health care providers with transactional, compliance, reimbursement, legislative and regulatory compliance issues. Loomis graduated with special distinction from the University of Oklahoma in 1991 and with honors from the University of Texas School of Law in 1994. She is a member of the Oklahoma Bar Association, Oklahoma County Bar Association, and the American Bar Association. In 2010, Loomis was listed in The Best Lawyers in America for Administrative/Regulatory Law by U.S. News Media Group and Best Lawyers and ranked by Chambers U.S.A. in Corporate/Commercial: Healthcare. She also received a Leadership in the Law award from the Journal Record in 2010 and was accepted to the Oklahoma Bar Association Leadership Academy in 2011. Loomis has been involved in numerous charitable and civic activities, including service as a member of the Oklahoma Board of Nursing, Community Health Charities Board, Prevent Blindness Board and Church of the Servant Administrative Council.
This online program supports the following browsers: Current production versions of Safari, Firefox, Edge and Chrome.
The online programs will include a mix of text, graphics and illustrations. Each online module complies with the components of the Oklahoma State Medical Association Continuing Medical Education Internet Policy as outlined below:
1. Complying with the OSMA Requirements and Policies
2. Separating education from promotion
3. Prohibiting CME activities from being on a pharmaceutical or device manufacturer’s website
4. Notifying the learner when leaving the educational website
5. Linking the website to pharmaceutical and device manufacturers websites is only permitted before or after the educational content
6. Advertising of any type is prohibited within the educational content of the activity
7. Informing the learner about the hardware and software needed to participate
8. Complying with and informing the learner about privacy and confidentiality of information, and
9. Complying with copyright laws